To include your compound in the COVID-19 Resource Center, submit it here.

Nexus Dx Alzheimer's disease test: SYY started a North American pivotal trial of its blood test in 530 patients at risk for AD and non-AD subjects.

Syn X Pharma Inc. (TSE:SYY), Toronto, Ontario
Product: Nexus

Read the full 93 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE